tiprankstipranks
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
ERMA
Enorama Pharma AB
RESEARCH TOOLSreports

Enorama Pharma AB (ERMA) Income Statement

Compare
0 Followers

Enorama Pharma AB Income Statement

Last quarter (Q4 2025), Enorama Pharma AB's total revenue was kr1.75M, a decrease of -33.74% from the same quarter last year. In Q4, Enorama Pharma AB's net income was kr-20.57M. See Enorama Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 2.74Mkr 15.77Mkr 1.36Mkr 6.85Mkr 11.04M
Gross Profit
kr -62.12Mkr 3.70Mkr -3.90Mkr -616.00Kkr 2.13M
Operating Expenses
kr 0.00kr 51.22Mkr 38.23Mkr 41.35Mkr 29.07M
Depreciation and Amortization
kr 469.00Kkr 20.41Mkr 677.00Kkr 3.54Mkr 663.00K
EBITDA
kr -61.65Mkr -20.41Mkr -43.05Mkr -37.22Mkr -26.28M
Operating Income
kr -62.12Mkr -47.52Mkr -41.84Mkr -41.47Mkr -26.94M
Other Income/Expenses
kr -13.02Mkr 3.71Mkr -2.77Mkr -560.00Kkr -802.00K
Pretax Income
kr -75.14Mkr -43.81Mkr -44.61Mkr -42.03Mkr -27.74M
Net Income
kr -75.14Mkr -43.81Mkr -44.61Mkr -41.78Mkr -28.54M
Per Share Metrics
Basic EPS
kr -1.08kr -0.83kr -1.33kr -4.40kr -3.80
Diluted EPS
kr -1.08kr -0.83kr -1.61kr -4.40kr -3.80
Weighted Average Shares Outstanding
 69.48M 53.04M 33.58M 9.49M 7.52M
Weighted Average Shares Outstanding (Diluted)
 69.48M 53.04M 27.70M 9.49M 7.52M
Currency in SEK

Enorama Pharma AB Earnings and Revenue History